Lawmakers in Both Parties Vow to Rein In Insulin Costs [The New York Times]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: The New York Times
Lawmakers in Both Parties Vow to Rein In Insulin Costs - The New York Times WASHINGTON — Members of Congress from both parties expressed immense frustration on Wednesday at big increases in insulin prices and vowed to work together on legislation to prevent more people from dying because they could not afford the lifesaving medicine. Representative Earl L. Carter, Republican of Georgia, said at the end of a three-hour hearing with pharmaceutical executives and middlemen, known as pharmacy benefit managers, “You’ve done something here today that we’ve been trying to do in Congress for years, and that is to create bipartisanship.” “This is going to end,” Mr. Carter, known as Buddy, said of the convoluted arrangements that drive up list prices of insulin and the out-of-pocket costs for many people with diabetes. The hearing was one of several indications that Congress was serious about trying to address the cries of distress from constituents unable to afford the medicines they need. Mr.
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Levodopa Market to Reach $2.9 Billion Globally By 2032 at 6.1% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive Vice President and Head of Research and Development, and Strengthens Scientific Advisory Board with the Addition of Dr. Adrian Acquire Media Monitor
- Eli Lilly and Company (LLY) Rose due to Robust Q4 Sales [Yahoo! Finance]Yahoo! Finance
- Uveitis Market Insight, Epidemiology and Market Forecast to 2034: Assessment of Competitors, Market, Current Trends and Upcoming Treatments [Yahoo! Finance]Yahoo! Finance
- Eli Lilly (LLY) Advances But Underperforms Market: Key Facts [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website